Intersect ENT Receives $55,000,000 New Financing Round

  • Feed Type
  • Date
    7/24/2014
  • Company Name
    Intersect ENT
  • Mailing Address
    1555 Adams Drive Menlo Park, CA 94025 USA
  • Company Description
    Intersect ENT Inc. (NASDAQ: XENT) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients.
  • Website
    http://www.intersectent.com
  • Transaction Type
    IPO
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

By posting a comment, you agree to our terms and conditions.